Immunic (IMUX) Operating Leases (2019 - 2026)

Immunic (IMUX) reported Operating Leases of $421000.0 for Q1 2026, down 56.82% on a YoY basis from $975000.0 in Q1 2025, and up 293.46% sequentially from $107000.0 in Q4 2025.

Immunic (IMUX) Operating Leases (2019 - 2026) Analysis & Trends

Immunic (IMUX) has 8 years of Operating Leases data on file, last reported at $421000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Operating Leases fell 56.82% year-over-year to $421000.0; the trailing twelve-month figure through Mar 2026 stood at $421000.0 (down 56.82% YoY), and the FY2025 full-year result was $107000.0, down 59.47% from the prior year.
  • Operating Leases improved to $421000.0 in Q1 2026, from $107000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $2.0 million in Q1 2023 to a low of $107000.0 in Q4 2025.
  • A 5-year average of $785705.9 and a median of $759000.0 in 2022 frame the typical range for Operating Leases.
  • Across the five-year window, Operating Leases jumped 298.61% in 2023 and tumbled 87.18% in 2024, its largest moves.
  • Tracing IMUX's Operating Leases over 5 years: stood at $992000.0 in 2022, then sank by 35.58% to $639000.0 in 2023, then slumped by 58.69% to $264000.0 in 2024, then sank by 59.47% to $107000.0 in 2025, then jumped by 293.46% to $421000.0 in 2026.
  • Business Quant data shows IMUX's Operating Leases at $421000.0 in Q1 2026, $107000.0 in Q4 2025, and $126000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Immunic 11.03 Mn 11.03 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 421,000.00
Dec 31, 2025 107,000.00
Sep 30, 2025 126,000.00
Jun 30, 2025 205,000.00
Mar 31, 2025 975,000.00
Dec 31, 2024 264,000.00
Sep 30, 2024 186,000.00
Jun 30, 2024 955,000.00
Mar 31, 2024 1.13 Mn
Dec 31, 2023 639,000.00
Sep 30, 2023 1.45 Mn
Jun 30, 2023 1.88 Mn
Mar 31, 2023 2.00 Mn
Dec 31, 2022 992,000.00
Sep 30, 2022 759,000.00
Jun 30, 2022 767,000.00
Mar 31, 2022 502,000.00
Dec 31, 2021 584,000.00
Sep 30, 2021 701,000.00
Jun 30, 2021 829,000.00